Compare GHG & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
| Metric | GHG | ALPS |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | China | Malaysia |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.6M | 158.8M |
| IPO Year | 2018 | N/A |
| Metric | GHG | ALPS |
|---|---|---|
| Price | $1.58 | $0.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.6K | ★ 57.1K |
| Earning Date | 12-23-2025 | 07-24-2026 |
| Dividend Yield | ★ 6.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $166,761,937.00 | $3,741,201.00 |
| Revenue This Year | $19.02 | N/A |
| Revenue Next Year | $8.26 | N/A |
| P/E Ratio | $6.56 | ★ N/A |
| Revenue Growth | N/A | ★ 26.69 |
| 52 Week Low | $1.60 | $0.56 |
| 52 Week High | $3.25 | $15.00 |
| Indicator | GHG | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 31.80 | N/A |
| Support Level | $1.63 | N/A |
| Resistance Level | $1.68 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.